Skip to main content

Table 4 Comorbidity levels according to different disability level groups

From: Effects of physical activity levels on characteristic pain in temporomandibular dysfunctions: a cross-sectional study

 

Low (n = 78)

High (n = 22)

P-value

ESS†

6.77 (4.49)

6.23 (3.38)

0.544

ESS > 10‡‡

18.18% (14/77)

13.64% (3/22)

0.756

PSQI†

7.90 (3.41)

7.91 (2.73)

0.987

PSQI ≥ 5‡

85.71% (66/77)

90.91% (20/22)

0.727

FAI†

4.14 (1.01)

4.43 (0.71)

0.207

FIQ†

29.39 (19.54)

31.78 (16.26)

0.605

FM diagnosis‡‡

1.30% (1/77)

13.64% (3/22)

0.033*

 WPI††

3.00 (2.00, 6.00)

4.00 (2.00, 5.00)

0.809

 SS†

4.71 (2.24)

5.05 (2.25)

0.546

COMPASS 31

 Orthostatic intolerance††

20.00 (8.00, 28.00)

22.00 (8.00, 28.00)

0.920

 Vasomotor††

1.67 (1.67, 1.67)

1.67 (1.67, 1.67)

0.871

 Secretomotor†

18.34 (3.19)

19.29 (2.69)

0.208

 Gastrointestinal††

15.18 (10.71, 16.96)

12.95 (9.15, 16.74)

0.247

 Bladder††

3.33 (3.33, 4.44)

3.33 (3.33, 3.33)

0.296

 Pupillomotor††

2.67 (1.00, 3.33)

1.00 (1.00, 3.25)

0.210

 Total†

60.85 (15.26)

59.58 (12.11)

0.723

CSI†

30.38 (17.59)

31.68 (15.43)

0.756

CSI ≥ 30‡

41.56% (38/77)

50% (11/22)

1.000

BDI†

8.45 (8.14)

9.41 (7.01)

0.622

BDI ≥ 30‡

1.30% (1/77)

0.00% (0/22)

1.000

BAI††

4.00 (2.00, 11.00)

5.00 (2.00, 10.25)

0.847

BAI ≥ 26‡‡

3.90% (3/77)

4.55% (1/22)

1.000

GAD-7†

4.03 (4.89)

4.09 (3.30)

0.982

PILL†

52.71 (31.98)

57.36 (31.87)

0.553

PILL > 84‡‡

18.18% (14/77)

13.64% (3/22)

0.756

PSS†

16.10 (7.37)

14.68 (7.05)

0.427

PSS > 13‡

62.34% (48/77)

50% (11/22)

0.332

TSK-TMD†

26.76 (6.71)

29.59 (5.01)

0.082

TSK-TMD ≥ 23‡‡

78.21% (61/78)

86.36% (19/22)

0.551

SF-36

 Physical functioning††

95.00 (80.00, 100.00)

95.00 (76.25, 100.00)

0.973

 Role physical††

100.00 (50.00, 100.00)

75 (31.25, 100.00)

0.080

 Role emotional††

100.00 (66.67, 100.00)

66.67 (41.67, 100.00)

0.073

 Energy/fatigue†

49.68 (20.39)

46.82 (19.75)

0.565

 Emotional well-being†

67.90 (20.02)

66.55 (14.46)

0.924

 Social functioning††

87.50 (67.50, 100.00)

87.50 (69.38, 90.00)

0.646

 Pain†

64.51 (21.98)

56.59 (19.81)

0.196

 General health†

53.44 (22.71)

54.09 (16.56)

0.804

PHQ-9†

4.41 (4.95)

5.50 (4.24)

0.354

PHQ-9 ≥ 20‡‡

1.28% (1/78)

0.00% (0/22)

1.000

PHQ-15†

5.76 (4.61)

6.45 (3.96)

0.524

PHQ-15 ≥ 15‡‡

6.41% (5/78)

4.55% (1/22)

1.000

Headache‡

41.56% (32/77)

63.64% (14/22)

0.408

  1. ESS: Epworth sleepiness scale, PSQI: Pittsburgh sleep quality index, FAI: Fatigue assessment instrument, FIQ: Fibromyalgia impact questionnaire, FM: Fibromyalgia, WPI: Widespread pain index, SS: Symptom severity scale, COMPASS 31: Composite autonomic symptom score 31, CSI: Central sensitization index, BDI: Beck depression index, BAI: Beck anxiety index, GAD-7: General anxiety disorder-7, PILL: Pennebaker index of limbic languidness, PSS: Perceived stress scale, TSK-TMD: Tampa scale of kinesiophobia for TMD, SF-36: Short form-36, PHQ-9: Patient health questionnaire-9, PHQ-15: Patient health questionnaire-15
  2. †Differences between groups were tested with independent t-test: mean (standard deviation)
  3. ††Differences between groups were tested with Mann-Whitney test: median (lower quartile, upper quartile)
  4. ‡Differences between groups were tested with chi-square test: number of subjects or positive palpation sites (%)
  5. ‡‡Differences between groups were tested with Fisher’s exact test: number of subjects or positive palpation sites (%)
  6. *Significant difference, p < 0.05